Overview
MIRAGE syndrome is a rare, multisystem congenital disorder characterized by myelodysplasia, immunodeficiency, growth restriction, adrenal hypoplasia, genital abnormalities, dysphagia, gastroesophageal reflux disease, and dysautonomia 1.Diagnosis
Key Diagnostic Criteria: Combined immunodeficiency, recurrent infections, growth restriction, adrenal insufficiency, hypogonadism (46,XY karyotype with hypovirilization), dysphagia, gastroesophageal reflux disease, and dysautonomia 1.
Recommended Tests:
- Ophthalmological evaluation including corneal sensation testing (Schirmer test, Teller Acuity Cards) 1.
- Brain MRI to assess lacrimal gland hypoplasia 1.
- Genetic testing for confirmation of MIRAGE syndrome characteristics 1.Management
First-Line Treatments:
- Management of adrenal insufficiency with appropriate hormone replacement therapy (specific doses not detailed in the abstract) 1.
- Supportive care for immunodeficiency, including prophylactic antibiotics and immunoglobulin replacement therapy 1.
Adjunctive Treatments:
- Frequent lubricating ointment for corneal epithelial defects 1.
- Nutritional support and management of gastroesophageal reflux disease 1.Special Populations
Pediatrics: Early ophthalmological intervention is crucial due to corneal complications like epithelial defects and decreased corneal sensation 1.Key Recommendations
Perform comprehensive ophthalmological evaluations including corneal sensation and imaging studies to assess lacrimal gland hypoplasia in patients with MIRAGE syndrome (Evidence: Moderate) 1.
Initiate hormone replacement therapy for managing adrenal insufficiency in MIRAGE syndrome patients (Evidence: Expert opinion) 1.
Provide prophylactic and supportive treatments for immunodeficiency and recurrent infections (Evidence: Expert opinion) 1.References
1 Basilious A, Basilious A, ElJalbout R, Robert MC. Lacrimal Gland Hypoplasia and Corneal Anesthesia in MIRAGE Syndrome: A Case Report and Literature Review. Cornea 2022. link